These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1780645)

  • 21. Regulatory Considerations and Evolving Technologies in Toxicologic Pathology. Proceedings of the Society of Toxicologic Pathologists 12th International Symposium. Alexandria, Virginia, June 27-July 1, 1993.
    Toxicol Pathol; 1994; 22(2):85-225. PubMed ID: 7973373
    [No Abstract]   [Full Text] [Related]  

  • 22. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Toxicol Pathol; 2009 Jun; 37(4):553-61. PubMed ID: 19458391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplement 1, Toxicologic Pathology, March/April 2004 should be must reading for all pathologists.
    Wagner BM
    Toxicol Pathol; 2004; 32(5):613. PubMed ID: 15603545
    [No Abstract]   [Full Text] [Related]  

  • 24. Global recognition of qualified toxicologic pathologists: credential review as a potential route for recognizing the proficiency of pathologists involved in regulatory-type nonclinical studies.
    Ettlin RA; Bolon B; Pyrah I; Konishi Y; Black HE
    Exp Toxicol Pathol; 2010 Jul; 62(4):413-22. PubMed ID: 19604680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies.
    Bolon Chair B; Barale-Thomas E; Bradley A; Ettlin RA; Franchi CA; George C; Giusti AM; Hall R; Jacobsen M; Konishi Y; Ledieu D; Morton D; Park JH; Scudamore CL; Tsuda H; Vijayasarathi SK; Wijnands MV
    Toxicol Pathol; 2010 Oct; 38(6):984-92. PubMed ID: 20716784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for pathology peer review.
    Morton D; Sellers RS; Barale-Thomas E; Bolon B; George C; Hardisty JF; Irizarry A; McKay JS; Odin M; Teranishi M
    Toxicol Pathol; 2010 Dec; 38(7):1118-27. PubMed ID: 20924082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the pathologist in GLP studies.
    Weber K; Hailey JR; Mann PC; Seaton M; Funk KA
    Toxicol Pathol; 2014 Jan; 42(1):275. PubMed ID: 24436040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicologic Pathology Forum*: Opinion on Considerations for the Use of Whole Slide Images in GLP Pathology Peer Review.
    Bradley A; Jacobsen M
    Toxicol Pathol; 2019 Feb; 47(2):100-107. PubMed ID: 30636543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scientific and Regulatory Policy Committee Points to Consider: Data Visualization for Clinical and Anatomic Pathologists.
    Troth SP; Everds NE; Siska W; Knight B; Lamb M; Hutt J
    Toxicol Pathol; 2018 Jul; 46(5):476-487. PubMed ID: 29843574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best practices for reporting pathology interpretations within GLP toxicology studies.
    Morton D; Kemp RK; Francke-Carroll S; Jensen K; McCartney J; Monticello TM; Perry R; Pulido O; Roome N; Schafer K; Sellers R; Snyder PW
    Toxicol Pathol; 2006; 34(6):806-9. PubMed ID: 17162539
    [No Abstract]   [Full Text] [Related]  

  • 31. Regulatory forum opinion piece: Peer review documentation and pathology data locking.
    Neef N
    Toxicol Pathol; 2014; 42(2):311-3. PubMed ID: 24357644
    [No Abstract]   [Full Text] [Related]  

  • 32. Society of toxicologic pathology position paper: diet as a variable in rodent toxicology and carcinogenicity studies.
    Nold JB; Keenan KP; Nyska A; Cartwright ME
    Toxicol Pathol; 2001; 29(5):585-6. PubMed ID: 11695576
    [No Abstract]   [Full Text] [Related]  

  • 33. Strengthening the peer review process for the International Journal of Toxicology.
    Brock WJ
    Int J Toxicol; 2014; 33(5):351-2. PubMed ID: 25436270
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter on behalf of the European college of veterinary clinical pathology in response to the article "international recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies".
    Bonfanti U; O'Brien P; Pinches M; Poitout F; Stirn M; von Beust B
    Toxicol Pathol; 2010 Oct; 38(6):993-4. PubMed ID: 21037201
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathology working groups.
    Mann PC; Hardisty JH
    Toxicol Pathol; 2014 Jan; 42(1):283-4. PubMed ID: 24190914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. al.
    Tripathi NK
    Toxicol Pathol; 2010 Dec; 38(7):1167. PubMed ID: 21248324
    [No Abstract]   [Full Text] [Related]  

  • 37. A commentary on the process of peer review and pathology data locking.
    McKay JS; Barale-Thomas E; Bolon B; George C; Hardisty J; Manabe S; Schorsch F; Teranishi M; Weber K
    Toxicol Pathol; 2010 Apr; 38(3):508-10. PubMed ID: 20237370
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathology peer review--a concept for consideration.
    Peters TS
    Toxicol Pathol; 1996; 24(5):654-6. PubMed ID: 8923693
    [No Abstract]   [Full Text] [Related]  

  • 39. Registry of toxicologic pathology for animals.
    Nold JB
    Toxicol Pathol; 1995; 23(5):622-3. PubMed ID: 8578106
    [No Abstract]   [Full Text] [Related]  

  • 40. The world weighs in on optimal toxicologic pathology training practices: it's unanimous!
    Bolon B
    Exp Toxicol Pathol; 2012 Sep; 64(6):597. PubMed ID: 21330120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.